HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prestige Fragrance At “Point Of Resurgence” In U.S. – NPD

This article was originally published in The Rose Sheet

Executive Summary

After years in decline, the U.S. prestige fragrance market is on an upswing based on strong 2010 launches and positive performance from existing brands, according to Karen Grant, NPD Group vice president and senior global industry analyst.

You may also be interested in...



Half-Way Into Lauder’s Strategic Plan, Targeted Prestige Driving Success

The Estee Lauder Companies is well on its way to fulfilling goals of a four-year strategy unveiled in 2009, crediting strong performances in emerging markets and growth of its prestige beauty brands.

Social Media Or Traditional Ads? Amid Uncertainty Some Constants Remain

In its new report, Kline & Company explores the issue of where funds and resources are being best implemented – in social media or traditional advertising. Questions remain, but there are some strategies that haven’t lost their effectiveness, no matter what channel you’re going through.

Travel Retail Sales To Take Flight, Reaching $60 Bil. By 2015

The beauty industry, no stranger to the travel retail business, is sitting pretty with sales in the channel projected to rise more than 50% from $39 billion in 2010 to $60 billion by 2015, according to Jérôme Goldberg, managing director of Paris-based JMG Research.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017656

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel